home of the INTERNATIONAL ATHEROSCLEROSIS SOCIETY
  ABOUT IAS  | IAS LEADERSHIP  | MEMBER SOCIETIES  | MEMBERSHIP contact us  | home   

IAS Prevention Guideline plus relevant cardiovascular guidelines from other organizations
Previous and future meetings sponsored by the IAS, the IAS member societies, or relevant affiliated organizations
Current and prior publications that have been sponsored by the IAS, including previous IAS newsletters
Distinguished Fellows of the IAS
Slides available through the IAS, Lorenzini Foundation, and other sites.
IAS monthly newsletter sent by email to all IAS members
Monthly summary of the key literature	in the atherosclerosis field provided each month to all IAS members.
The IAS offers fellowships to young investigators to study in major laboratories
Important websites related to atherosclerosis and related diseases
Computer based algorithms for 10-year risk assessment for cardiovascular disease.
Organizations affiliated with the IAS.


IAS Statin Publication
Update Service


The International Atherosclerosis Society is very pleased to announce an exciting new and informative Newsletter for its membership: The IAS Statin Newsletter. The IAS will begin this month providing curated update on all publications involving statins as identified in PubMed.
For the Issues, click here

ISA 2018 Toronto, Canada

June 9-12, 2018

XVIII International Symposium on
Atherosclerosis
Toronto, Canada

Fellowship Awards
Winners 2017


Kepa Belloso-Uribe
Leioa, Spain


Fernando Giuffrida
Salvador, BA, Brazil


Zhihan Tang
Hengyang, Hunan, China


Paolo Zanoni
Schlieren, Switzerland


Winner Reports
Winner 2016 - Blake Cochran
Winner 2016 - Ingo Hilgendorf
Winner 2016 - Yosdel Soto
Winner 2015 - Hagit Hochner
Winner 2015 - Kazuyuki Kasahara
Winner 2015 - Wei Tan
Winner 2014 - Amanda Foks
Winner 2014 - Nordin Hanssen
Winner 2014 - Marco Busnelli

last updated: May 16, 2018 

ATTENTION! To access some of the content on athero.org you must be a registered user and you must log on.
You can use the interface on the right side of this page to either log on or to register.
  From the IAS President's Desk

We look forward to welcoming you to the XVIIII International Symposium on Atherosclerosis (ISA 2018) to be held in Toronto, Canada from June 9-12, 2018. It is our pleasure to invite you to join us for what promises to be one of the most exciting global meetings on atherosclerosis, thrombosis and vascular biology.

Since 1966, the International Atherosclerosis Society (IAS) has held triennial meetings to bring together top clinicians, researchers, and health practitioners from around the world. This meeting will also provide an opportunity for its attendees to participate in public health awareness and innovation forums focused on cardiovascular health.



  IAS FH Activities

Screening Project for Familial Hypercholesterolemia in Central, Southern, and Eastern Europe-ScreenPro

The ScreenPro FH Project started in 2014/2015. Based on the Czech MedPed experience the project was established for screening, diagnosis and treatment of FH patients in the region of Central, Eastern and Southern Europe.

  • We started with 8 countries, now we are 20.
  • We started with 70 centers, now we are 181 (other 40 in development).
  • We started with 7500 patients in the local databases, now, they are 23 191.
  • We started cooperation with patient´s organization in 8 countries (2017).
  • We focus on education, screening and care of FH patients. Nowadays we are on the way from description of the situation to improvement in the treatment.

You can view it here and here

Severe FH Course “IDENTIFYING AND TREATING SEVERE FAMILIAL HYPERCHOLESTEROLEMIA” (Dubai, UAE, October 14-15, 2017)

The International Atherosclerosis Society (IAS), the Oman Society of Lipid and Atherosclerosis (OSLA), the Gulf Heart Association (GHA), and the Emirates Cardiac Society (ECS), are happy to make available to our readers some important documents related to the Course on Identifying and Treating Severe Familial Hypercholesterolemia which was held in Dubai, UAE on October 14-15, 2017. The Course was co-chaired by Profs. Raul Santos (President-Elect of IAS), Khalid Al-Rasadi (President, OSLA) and Wael Almahmeed (Board Member of GHA).


IAS SEVERE FH PANEL

IAS Consensus Statement “Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel”

The International Atherosclerosis Society (IAS) is proud to announce the publication on the definition of severe FH and the implications for clinical management in The Lancet Diabetes and Endocrinology. The IAS Severe FH Panel, made of 25 internationally renowned experts and chaired by Dr. Raul Santos, worked with the objective of characterizing the severe FH phenotype and made recommendations on how to stratify CVD risk and to whom to prescribe the novel lipid lowering treatments. These recommendations will contribute to improved daily clinical practice and better management of FH patients.

To download the full text, which is open access, please link to and register at http://www.thelancet.com/journals/landia/article/PIIS2213-8587(16)30041-9/fulltext (Published online May 27, 2016). For more information about The Lancet, please visit The Lancet Homepage at www.thelancet.com.


Other FH activities

NEW DATA ON FAMILIAL HYPERCHOLESTEROLEMIA IN BRAZIL
For the abstract and full article please click here


LAUNCH E-LEARNING

Improving management through genetic testing for Familial Hypercholesterolaemia (FH)

This e-learning has been developed for healthcare professionals with an interest in FH and genetic testing by a panel of world renowned experts in this area, Pr. Carrie and Pr. Bruckert from France, and Dr. Ballantyne and Dr. Eng in the USA and is approved by the International Atherosclerosis Society (IAS).
On completion of this e-learning you will have a better understanding of:

  • Key aspects of genetic testing in Familial Hypercholesterolaemia (FH)
  • How and why to use genetic testing
  • How to interpret results
  • How to use cascade screening to identify related individuals at risk
You can view the e-learning at https://checkpoint.cor2ed.com/


NEWS FROM THE LIPID CLINICS in IRAQ

The success story deriving from the educational activities of the IAS and OSLA in the MENA Region continues. Thanks to the efforts of Dr. Mutaz Al-Sabah and his Iraqi colleagues at the moment 8 Lipid clinics have been established throughout the country:

  1. Al-Diwaniya city
    Al-Diwaniya teaching hospital

     
  2. Al-Sulaimaniya city
    Shorsh military teaching hospital

     
  3. Al-Samawa city
    Al-Samawa teaching hospital

     
  4. Salahaldeen city
    Balad teaching hospital

     
  5. Al-Ramadi city
    Al-Ramadi teaching hospital

     
  6. Al-Fallujah city
    Al-Fallujah teaching hospital
     
  7. Erbil city
    Rizgary teaching hospital

     
  8. Kirkuk city
    Kirkuk lipid clinic

We would love to hear from our member societies about other such exciting and important successes in the field throughout the world and look forward to hearing from you.


The SAFEHEART Registry

Risk factors for atherosclerotic cardiovascular disease (ASCVD) are variable among patients with Familial Hypercholesterolaemia (FH). SAFEHEART is a multicentre, nationwide, long-term prospective contemporary cohort study of a molecularly defined FH population with or without previous ASCVD. A robust risk prediction equation (SAFEHEART-RE) has been developed using this unique cohort that shows that the risk of incident ASCVD may be estimated in FH patients using clinical and laboratory parameters including age, gender, history of ASCVD, blood pressure, body mass index, smoking, and plasma LDL-C and lipoprotein (a) levels. The Harrell's C index for this model was 0.85.
This information will allow more accurate ASCVD risk prediction in FH and will potentially increase the efficiency of care and use of newer lipid lowering therapies. The SAFEHEART-RE is an accurate tool to implement these predictors in daily clinical practice.

You can view it here


  IAS - OSLA Collaboration in the MENA Region

The International Atherosclerosis Society (IAS) and Oman Society of Lipid & Atherosclerosis (OSLA) are organizing the Fifth IAS-OSLA Course "Lipid Metabolism and Cardiovascular Risk" to be held in Muscat, Oman, on February 8-12, 2019.
As in 2015, 2016, 2017 and 2018, the aim of this Course is to increase the knowledge and experience of early- to mid-career, English-speaking practicing clinicians interested in the management of lipid disorders and will be restricted to 30 clinicians from the Middle East and North Africa (MENA) region who manage patients with lipid disorders.

Who can apply: Clinicians (including adult or pediatric cardiologists, endocrinologists, general practitioners, lipidologists, clinical biochemists) below the age of 40 years who are currently working at a hospital/university/other health institute in the MENA region.

More information will follow.


  IAS Commentaries

  Meeting and Educational Activity Highlights
To view all highlights, please click here

  Acknowledgements
The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission:
Aegerion Pharmaceuticals, Amgen, Inc., Amgen (Europe) GmbH, Amryt, Daiichi Sankyo Co., Ltd., Fondazione Giovanni Lorenzini, OSLA - Oman Society of Lipids and Atherosclerosis, Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd.,Pfizer, Sanofi and Regeneron, and Weill Cornell Medical College


Disclaimer - Cookie policy
This site is optimised for a min. 1024 x 768 pixels resolution

REGISTERED USER
USER ID


PASSWORD




Remember my password


Forgot your password?
Click here


First-time user?
Click here


WHO IS IAS

The International Atherosclerosis Society (IAS), incorporated in 1979, promotes, at an international level, the advancement of science, research and teaching in the field of atherosclerosis and related diseases.

IAS Newsletter Editors & Website Editorial Board

Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta
Milan, Italy

Emanuela Folco
Milan, Italy

Ann Jackson
Houston, TX, USA

Commentary & Newsletter Editor
Yelonda Williams
(Dallas, TX, USA)

Elena Colombo
(Milan, Italy)